Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib

Koji Miyahara, Kazuhiro Nouso, Yasuhiro Miyake, Shinichiro Nakamura, Shuntaro Obi, Maho Amano, Kazuko Hirose, Shin Ichiro Nishimura, Kazuhide Yamamoto

Research output: Contribution to journalLetter

18 Citations (Scopus)
Original languageEnglish
Pages (from-to)355-356
Number of pages2
JournalHepatology
Volume59
Issue number1
DOIs
Publication statusPublished - Jan 1 2014

ASJC Scopus subject areas

  • Hepatology

Cite this

Miyahara, K., Nouso, K., Miyake, Y., Nakamura, S., Obi, S., Amano, M., Hirose, K., Nishimura, S. I., & Yamamoto, K. (2014). Serum glycan as a prognostic marker in patients with advanced hepatocellular carcinoma treated with sorafenib. Hepatology, 59(1), 355-356. https://doi.org/10.1002/hep.26531